FDA orphan drug designation: treatment of congenital amegakaryocytic thrombocytopenia
All entries for: HemaCell Biotechnology Inc.
July 28, 2025
HemaCell Biotechnology Inc.
Orphan Drug Designation
Disease Area: Rare Diseases
FDA orphan drug designation: treatment of congenital amegakaryocytic thrombocytopenia
